| D |
2026-08-05 16:18 |
2026-08-03 |
APMD |
Apnimed, Inc. |
Morningside Venture Investments Ltd |
10% |
C - Cnv Deriv |
— |
+6.84M |
6.84M |
New |
— |
| DM |
2026-08-05 16:18 |
2026-08-03 |
APMD |
Apnimed, Inc. |
Morningside Venture Investments Ltd |
10% |
J - Other |
— |
0 |
6.84M |
New |
— |
| D |
2026-08-05 16:18 |
2026-08-03 |
APMD |
Apnimed, Inc. |
Morningside Venture Investments Ltd |
10% |
P - Purchase |
$16.00 |
+312.5K |
7.15M |
+5% |
+$5.00M |
| DI |
2026-08-05 16:18 |
2026-08-03 |
APMD |
Apnimed, Inc. |
Morningside Venture Investments Ltd |
10% |
C - Cnv Deriv |
$14.40 |
+75.6K |
75.6K |
New |
+$1.09M |
| DMI |
2026-08-05 16:18 |
2026-08-03 |
APMD |
Apnimed, Inc. |
Morningside Venture Investments Ltd |
10% |
J - Other |
— |
0 |
75.6K |
New |
— |
|
2023-08-17 |
2023-08-15 |
AMLX |
Amylyx Pharmaceuticals, Inc. |
Morningside Venture Investments Ltd |
10% |
G - Gift |
$0.00 |
-2.00M |
5.00M |
-29% |
$0 |
|
2023-03-31 |
2023-03-29 |
AMLX |
Amylyx Pharmaceuticals, Inc. |
Morningside Venture Investments Ltd |
10% |
S - Sale |
$30.45 |
-29.0K |
7.00M |
-0.4% |
-$884.5K |
| M |
2023-03-29 |
2023-03-27+ |
AMLX |
Amylyx Pharmaceuticals, Inc. |
Morningside Venture Investments Ltd |
10% |
S - Sale |
$30.42 |
-161.0K |
7.03M |
-2% |
-$4.90M |
| M |
2023-03-23 |
2023-03-21 |
AMLX |
Amylyx Pharmaceuticals, Inc. |
Morningside Venture Investments Ltd |
10% |
S - Sale |
$31.91 |
-63.4K |
7.22M |
-0.9% |
-$2.02M |
|
2023-03-17 |
2023-03-16 |
AMLX |
Amylyx Pharmaceuticals, Inc. |
Morningside Venture Investments Ltd |
10% |
S - Sale |
$32.55 |
-9,122 |
7.25M |
-0.1% |
-$296.9K |
| M |
2023-03-16 |
2023-03-14+ |
AMLX |
Amylyx Pharmaceuticals, Inc. |
Morningside Venture Investments Ltd |
10% |
S - Sale |
$33.68 |
-220.7K |
7.41M |
-3% |
-$7.43M |
|
2023-03-06 |
2023-03-02 |
AMLX |
Amylyx Pharmaceuticals, Inc. |
Morningside Venture Investments Ltd |
10% |
S - Sale |
$33.75 |
-50.0K |
7.48M |
-0.7% |
-$1.69M |
| M |
2023-02-28 |
2023-02-22 |
AMLX |
Amylyx Pharmaceuticals, Inc. |
Morningside Venture Investments Ltd |
10% |
S - Sale |
$34.73 |
-50.0K |
7.53M |
-0.7% |
-$1.74M |
| M |
2023-02-24 |
2023-02-22+ |
AMLX |
Amylyx Pharmaceuticals, Inc. |
Morningside Venture Investments Ltd |
10% |
S - Sale |
$35.78 |
-100.0K |
7.64M |
-1% |
-$3.58M |
| D |
2022-01-25 |
2022-01-11 |
AMLX |
Amylyx Pharmaceuticals, Inc. |
Morningside Venture Investments Ltd |
10% |
P - Purchase |
$19.00 |
+263.2K |
10.68M |
+3% |
+$5.00M |
| D |
2022-01-25 |
2022-01-11 |
AMLX |
Amylyx Pharmaceuticals, Inc. |
Morningside Venture Investments Ltd |
10% |
C - Cnv Deriv |
— |
+10.42M |
10.42M |
New |
— |